Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Cell Reports
|
April 18, 2025
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy
Yu Fu, Xiaoyan Kang, Wenting Li, et al.
Aging
|
December 4, 2021
Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors
Tianyu Qin, Ensong Guo, Funian Lu, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2023
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
Yu Fu, Bin Yang, Yaoyuan Cui, et al.
Cancer Science
|
June 6, 2022
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma
Dianxing Hu, Ensong Guo, Bin Yang, et al.
Nature Communications
|
June 10, 2021
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
Bin Yang, Junpeng Fan, Jia Huang, et al.
Cell Reports. Medicine
|
July 10, 2024
Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancer
Tianyu Qin, Zhe Hu, Li Zhang, et al.
Nature Genetics
|
November 21, 2023
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance
Junpeng Fan, Funian Lu, Tianyu Qin, et al.
Cancer Letters
|
December 23, 2021
AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway
Chen Liu, Yuhan Huang, Tianyu Qin, et al.
Cell Reports. Medicine
|
December 21, 2022
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
Bin Yang, Xiong Li, Wei Zhang, et al.
Science Translational Medicine
|
March 12, 2025
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models
Xingyuan Hu, Xiaoyan Kang, Faming Zhao, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Cell Reports
|
April 18, 2025
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy
Yu Fu, Xiaoyan Kang, Wenting Li, et al.
Aging
|
December 4, 2021
Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors
Tianyu Qin, Ensong Guo, Funian Lu, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2023
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
Yu Fu, Bin Yang, Yaoyuan Cui, et al.
Cancer Science
|
June 6, 2022
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma
Dianxing Hu, Ensong Guo, Bin Yang, et al.
Nature Communications
|
June 10, 2021
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
Bin Yang, Junpeng Fan, Jia Huang, et al.
Cell Reports. Medicine
|
July 10, 2024
Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancer
Tianyu Qin, Zhe Hu, Li Zhang, et al.
Nature Genetics
|
November 21, 2023
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance
Junpeng Fan, Funian Lu, Tianyu Qin, et al.
Cancer Letters
|
December 23, 2021
AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway
Chen Liu, Yuhan Huang, Tianyu Qin, et al.
Cell Reports. Medicine
|
December 21, 2022
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
Bin Yang, Xiong Li, Wei Zhang, et al.
Science Translational Medicine
|
March 12, 2025
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models
Xingyuan Hu, Xiaoyan Kang, Faming Zhao, et al.
Page
of 4